Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (627K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Bolonkin D, Tate RL, Luber JH, Kohn LD, Winand RJ. Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem. 1975 Aug 25;250(16):6516–6521.[PubMed]
Chabaud O, Lissitzky S. Thyrotropin-specific binding to human peripheral blood monocytes and polymorphonuclear leukocytes. Mol Cell Endocrinol. 1977 Mar;7(1):79–87.[PubMed]
Hart IR, McKenzie JM. Comparison of the effects of thyrotropin and the long-acting thyroid stimulator on guinea pig adipose tissue. Endocrinology. 1971 Jan;88(1):26–30.[PubMed]
Kohn LD, Winand RJ. Structure of an exophthalmos-producing factor derived from thyrotropin by partial pepsin digestion. J Biol Chem. 1975 Aug 25;250(16):6503–6508.[PubMed]
Konishi J, Herman MM, Kriss JP. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology. 1974 Aug;95(2):434–446.[PubMed]
Kriss JP, Konishi J, Herman M. Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res. 1975;31:533–566.[PubMed]
Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RJ, Kohn LD. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology. 1977 Feb;100(2):351–366.[PubMed]
Munro RE, Lamki L, Row VV, Volpé R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab. 1973 Aug;37(2):286–292.[PubMed]
Winand RJ, Kohn LD. Stimulation of adenylate cyclase activity in retro-orbital tissue membranes by thyrotropin and an exophthalmogenic factor derived from thyrotropin. J Biol Chem. 1975 Aug 25;250(16):6522–6526.[PubMed]
Winand R, Mahieu P. Prevention of malignant exophthalmos after treatment of thyrotoxicosis. Lancet. 1973 May 26;1(7813):1196–1196.[PubMed]
Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press